BR100 Decreased By (-1.27%)
BR30 Decreased By (-3.01%)
KSE100 Decreased By (-2.48%)
KSE30 Decreased By (-2.5%)
BECO 5.39 Decreased By ▼ -0.21 (-3.75%)
BML 65.81 Increased By ▲ 4.86 (7.97%)
BOP 35.93 Decreased By ▼ -1.44 (-3.85%)
CNERGY 8.72 Increased By ▲ 0.23 (2.71%)
DCL 11.19 Decreased By ▼ -0.56 (-4.77%)
FCCL 56.18 Decreased By ▼ -1.57 (-2.72%)
FCSC 5.20 Increased By ▲ 0.16 (3.17%)
FFL 17.53 Decreased By ▼ -0.36 (-2.01%)
FNEL 1.27 Increased By ▲ 0.03 (2.42%)
HUMNL 11.02 Decreased By ▼ -0.18 (-1.61%)
KEL 7.86 Decreased By ▼ -0.25 (-3.08%)
KOSM 6.06 Decreased By ▼ -0.31 (-4.87%)
MLCF 102.17 Decreased By ▼ -4.89 (-4.57%)
NBP 211.65 Decreased By ▼ -6.66 (-3.05%)
PACE 12.29 Increased By ▲ 1.12 (10.03%)
PAEL 44.65 Decreased By ▼ -2.37 (-5.04%)
PIAHCLA 29.16 Decreased By ▼ -1.50 (-4.89%)
PIBTL 17.83 Decreased By ▼ -0.79 (-4.24%)
PPL 238.78 Decreased By ▼ -8.04 (-3.26%)
PRL 38.43 Increased By ▲ 1.18 (3.17%)
PTC 70.36 Decreased By ▼ -1.24 (-1.73%)
SEARL 95.06 Decreased By ▼ -4.10 (-4.13%)
SSGC 30.30 Decreased By ▼ -1.64 (-5.13%)
TELE 9.00 Decreased By ▼ -0.18 (-1.96%)
THCCL 70.57 Decreased By ▼ -3.63 (-4.89%)
TPLP 12.65 Decreased By ▼ -0.67 (-5.03%)
TREET 24.86 Decreased By ▼ -1.00 (-3.87%)
TRG 64.50 Decreased By ▼ -3.00 (-4.44%)
WAVES 10.94 Decreased By ▼ -0.57 (-4.95%)
WTL 1.33 Increased By ▲ 0.06 (4.72%)

It is not at all that prescribing the drugs by their market names is wrong. There is something to think about the fact whether it would be more transparent and in the benefits of the patients to write the drugs by the brand names. There are plenty of renowned pharmaceutical companies that charge the costly and hefty amount for the same drug which the other new smaller scale pharmaceutical companies are selling for less. The point is that why there is a difference in drugs when the same chemical is being sold in different packings.

Since the issue we are discussing is very delicate and believe the whole pharmaceutical world would defend writing the medicines by the brand names. After all, for the pharmaceutical companies, it is their business. However, I am more concerned with the poor patients who have to run after the costly medicines just because their medical doctor has prescribed the brand name. I wish, there was a system to write the generic names to make it more cost-effective and time-effective for the poor and needy patients.

(Concluded)

Dr. Batool Hassan

B.Sc., BS (US), MBBS, PGD HCM, CHQP, RMP.

Email [email protected]

Copyright Business Recorder, 2021

Dr Batool Hassan

The author is a registered medical practitioner, specialising in healthcare quality, clinical research, public health, and hospital administration. She can be reached at [email protected]

Comments

Comments are closed for this article.